We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-5.50 | -0.41% | 1,335.00 | 1,333.50 | 1,334.00 | 1,340.00 | 1,324.50 | 1,330.00 | 4,678,340 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.56B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/12/2022 20:13 | So the pharmacy are all pushing drugs but burning fossil fuels is fine. Think u just lost your ethical stance! I ain't getting on no plane.... fool! | mattboxy | |
29/12/2022 21:41 | If anyone ever needed some pharmaceuticals letsdothis is a prime candidate. Care in the community doesn't work! | mattboxy | |
29/12/2022 18:15 | This is definitely a buy! buy! buy! | paul planet earth | |
29/12/2022 13:31 | 10000000 new cases being exposed soon of there drugs affecting people | letsdothis | |
29/12/2022 11:44 | Letsdothis: User successfully filtered. You will no longer be able to read his/her posts | tradermichael | |
28/12/2022 20:00 | Hopefully 2023 will be a good year for gak sp | alibizzle | |
25/12/2022 09:49 | Let's just use this thread? | tradermichael | |
24/12/2022 16:41 | GlaxoSmithKline – defensive attractions The pharmaceutical sector tends to offer defensive attractions as doctors and patients are always in need of the companies’ products, regardless of the machinations of the worldwide economy. Shares in GlaxoSmithKline recently got a shot in the arm after a US judge threw out 2,500 major lawsuits that claimed its heartburn drug Zantac caused cancer. Analysts at broker Morgan Stanley had been concerned that the issue could have cost the company $45 billion in compensation claims. While there is still the possibility of individual lawsuits against Glaxo, this ruling ends a substantial concern for investors and a major overhang on the shares. | bountyhunter | |
24/12/2022 16:15 | Q3 dividend pays out on 12 January 2023. Not long now ;o) | tradermichael | |
24/12/2022 12:52 | I have every confidence in GSK’s future prospects and turnaround strategy buy buy buy! | paul planet earth | |
24/12/2022 01:16 | Merry Xmas cya Wednesday | letsdothis | |
23/12/2022 21:44 | GSK is a Shares Mag tip for 2023 | bountyhunter | |
23/12/2022 13:22 | Another twonk appears.. wonder if there is a limit to my filter list? ;) | rikky72 | |
23/12/2022 12:07 | Wishing you all a merry Xmas From the shorts & the BOILER ROOM exposing team enjoy your holidays & remember family is the most important thing EVER money is EASY to replace family can't be replaced WITH NO AMOUNT OF MONEY | letsdothis | |
23/12/2022 11:50 | I would advise to be MEGA CARFUL | letsdothis | |
23/12/2022 11:50 | BANKRUPTCY could loom | letsdothis |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions